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Incidence of Laryngospasm and Bronchospasm in Pediatric
Adenotonsillectomy
Michael I. Orestes, MD; Lina Lander, ScD; Susan Verghese, MD; Rahul K. Shah, MD
Objectives/Hypothesis: To evaluate and describe airway complications in pediatric adenotonsillectomy.
Study Design: Retrospective case-control study.
Methods: A chart review of patients that underwent adenotonsillectomy between 2006 and 2010 was performed. Peri-
operative complications, patient characteristics, and surgeon and anesthesia technique were recorded.
Results: A total of 682 charts were reviewed. Eleven cases (1.6%) of laryngospasm were identified: one was preopera-
tive, seven occurred in the operating room postextubation, and three occurred in the recovery area. Four patients were given
succinylcholine, one was reintubated, and the other cases were managed conservatively. Mean age of patients with laryngo-
spasm was 5.87 years (standard deviation [SD], 4.01; 1.9–15.8 years). There were 12 cases (1.8%) of bronchospasm; all were
treated with nebulized albuterol. Mean age of patients with bronchospasm was 5.81 years (SD, 4.17; 1.8–14.1 years). Overall,
22 patients required antiemetics (3.3%), 19 required albuterol (2.9%), and five required racemic epinephrine (0.8%). Com-
pared to the children without airway complications, there was no difference in age, weight, American Society of Anesthesiolo-
gists status, length of surgery, need for admission, and anesthesia technique in those that had laryngospasm. Patients with
bronchospasm, compared to the patients without complications, had faster surgeries (P < .05), were more likely to have
underlying asthma (P < .05), and were more likely to be admitted (P < .05). There were no unexpected admissions or other
morbidities.
Conclusions: The rates of laryngospasm (1.6%) and bronchospasm (1.8%) are significantly lower than reported in the
literature, reflecting refinements in modern anesthesia/surgical technique. Knowledge of at-risk patients can facilitate plan-
ning to potentially reduce the incidence of perioperative airway complications during adenotonsillectomy.
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INTRODUCTION
Pediatric adenotonsillectomy remains one of the
most common surgical procedures in the United States.1
In the past few decades, there have been significant
advances in the surgical technique, anesthetic
approaches, and recovery and postoperative manage-
ment of these patients. As a result, the outcomes and
resultant morbidity have significantly improved.2 One of
the most feared complications of pediatric adenotonsil-
lectomy is airway complications.3,4 These complications
can occur during adenotonsillectomy or in the periopera-
tive period and may include laryngospasm and
bronchospasm and result in significant morbidity and
prolonged hospitalization for the patient.5,6 Such compli-
cations require intense, rapid response from the
anesthesia and surgical team as well as comprehensive
postoperative monitoring around the time of the event.
As outcomes have improved for pediatric adenoton-
sillectomy, the surgery is now performed more
frequently in higher-risk populations such as younger
children and children with syndromes and craniofacial
abnormalities.4,7
Despite the frequency of this surgery, the incidence
and significance of perioperative airway complications in
this cohort of patients has not recently been studied.
Indeed, the historic citations of the rates of laryngo-
spasm and bronchospasm for adenotonsillectomy have
not been recently updated.8,9 With advanced surgical
techniques and refined anesthetic approaches with
faster-acting anesthetic agents resulting in faster recov-
ery times, the role that airway complications play in the
overall outcomes of these patients is significant.
The objective of this study is to evaluate a single
surgeon’s experience at a tertiary care academic medical
center to obtain a current rate of airway complications
during the perioperative period for adenotonsillectomy
as well as determine the outcomes and management of
these patients with the anticipation that identification of
high-risk patients for such complications will allow sur-
gery in these patients to be tailored as needed.
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MATERIALS AND METHODS
Institutional review board approval from Children’s
National Medical Center was obtained. Patients that underwent
adenotonsillectomy by the senior author (R.K.S.) were enrolled in
the study. In an attempt to control for as many variables as pos-
sible, it was deemed appropriate to use data from only one
surgeon, as it enabled comparison of myriad variables without
the confounding variable of different surgeons. We included
patients who underwent an adenotonsillectomy between August
2006 and December 2010 at either the main campus operating
room or the ambulatory surgery center at Children’s National
Medical Center.
Each patient’s chart was reviewed in totality to extract
pertinent information such as patient characteristics (demo-
graphics and complications) including the American Society of
Anesthesiologists (ASA) Physical Status classification, perioper-
ative data (length of surgery, time of recovery, disposition
status), intraoperative data (medications administered, oxygen
saturation characteristics), and postoperative outcomes and
complications. For all cases with airway complications, the sen-
ior authors (S.V., R.K.S.) reviewed each chart in detail.
For bronchospasm, the authors erred on the side of cau-
tion in classifying a case as such—for example, if the patient
received albuterol, the patient was considered to have increased
airway reactivity and hence we classified this patient as having
bronchospasm. Because this was a retrospective review, it was
nearly impossible to know for sure whether intraoperative bron-
chospasm actually occurred. Hence, administration of albuterol
was used as a surrogate marker for such. Comorbid conditions
for the patients were recorded and included asthma, gastro-
esophageal reflux disease, sickle cell, trisomy 21, and failure to
thrive.
Statistical analysis was performed to calculate significance
for these variables for the respective airway complications.
RESULTS
A total of 682 charts were reviewed (54% male);
patient ages ranged from 0.7 to 19.3 years, and patients
underwent adenotonsillectomy with a mean duration of
surgery of 19.6 minutes in those patients without airway
complications (Table I). The average weight of the
patients in the noncomplication group was 34.4 kg.
Patients were classified as follows: 34% were ASA 1,
61% were ASA 2, and 5% were ASA 3.
Eleven cases (1.6%) of laryngospasm were identi-
fied: one was following anesthetic induction before
surgery, seven occurred in the operating room postextu-
bation, and three occurred in the recovery area. Four
were given succinylcholine, one was reintubated, and
the other cases were managed conservatively. Mean age
of patients with laryngospasm was 5.87 years (standard
deviation [SD], 4.01; 1.9–15.8 years). There were 12
cases (1.8%) of bronchospasm or increased airway resist-
ance; all were treated with nebulized albuterol using a
metered-dose inhaler. Mean age of patients with bron-
chospasm was 5.81 years (SD, 4.17; 1.8–14.1 years).
Overall, 22 patients required additional antiemetics
(3.3%), 19 needed albuterol (2.9%), and five required
racemic epinephrine (0.8%).
Table I lists each variable studied and the incidence
and significance with regard to those patients at risk for
laryngospasm and bronchospasm. Compared to the
children without airway complications, those that had
laryngospasm showed no difference in age, weight, ASA
status, length of surgery, need for admission, and anes-
thesia technique. Patients with bronchospasm, compared
to the patients without complications, had faster sur-
geries (P < .05), were more likely to have asthma (P <
.05), and were more likely to be admitted (P < .05).
There were no other morbidities and no mortalities in
the patients reviewed.
DISCUSSION
Pediatric adenotonsillectomy is one of the most com-
mon surgeries performed in the United States.1 There
have been significant advances in the surgical technique,
anesthesia technique, and characteristics of patients
undergoing surgery in the past decades. This is juxta-
posed by external forces to shorten the length of stay of
patients and perhaps to minimize the need for patients to
remain in a monitored setting.4 A recent, robust,
prospective study outlined risk factors for a child under-
going pediatric anesthesia.10 Some of these included a
positive respiratory history, upper respiratory tract infec-
tion when symptoms were present 2 weeks before the
procedure, and a history of at least two family members
having asthma, atopy, or smoking.10 In our recent anec-
dotal experience, we have noted a significant decrease in
the rate of perioperative airway complications in
pediatric adenotonsillectomy. However, a literature review
demonstrates that there have not been recent studies
supporting this sentiment. As such, the present study
was conducted to examine this hypothesis.
In our study population, an inner city, tertiary-care,
free-standing, academic medical center with fellowship
trained pediatric otolaryngologists and fellowship-trained
pediatric anesthesiologists, the rate of laryngospasm and
bronchospasm in pediatric adenotonsillectomy was 1.6%
and 1.8%. Historically, and in other institutions, the rate
of laryngospasm and bronchospasm has been noted to be
significantly higher. A recent study comparing laryngeal
mask airway to endotracheal tube intubation for manag-
ing the airway in pediatric adenotonsillectomy identified
rates of laryngospasm of 12.5% in the laryngeal mask air-
way cohort and 9.6% in the intubated patients; this is
higher than our rate by almost an order of magnitude.11
Their findings are supported by other studies with a rate
of about 8% in a large study conducted over 4 years with
more than 1,000 patients.6 A study from 2 decades prior
noted that the use of topical lidocaine reduced the rate of
laryngospasm from 12% to 3%.8 Similarly, a comparison of
anesthesia techniques found that using propofol reduced
the rate of laryngospasm from 20% to 6.6%; however, the
sample size in that study was quite small.5 Patient char-
acteristics can, of course, affect the rate of airway
complications as noted in the study by Mitchell and Kelly,
as almost one-quarter of the young children in the group
undergoing surgery had postoperative complications
including laryngospasm and marked desaturations.12
Interestingly, in the general pediatric population
that undergoes surgery, the risk of laryngospasm has
been shown to be increased in children with upper respi-
ratory tract infection, a preexisting airway anomaly, or
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when a laryngeal mask airway was utilized.13 A rate of
bronchospasm of 1.5% in healthy children was reported
in a study comparing healthy children with those with
respiratory tract infections. Children with such infec-
tions were able to have the rate of bronchospasm and
coughing reduced by use of a b-2 agonist.14 These
authors showed that children at high risk for
perioperative adverse events could be assessed preopera-
tively by using highly specific and selective questions at
the telephone screening.14 This early screening can help
triage specific perioperative prophylactic therapy as well
as tailor the specific anesthetic to potentially decrease
these respiratory complications. Early effective commu-
nication between the pediatrician, pulmonologist (as
needed), otolaryngologist, preoperative screening nurse,
parents, anesthesiologist, and the postanesthesia care
unit nurse is critical in assessing the risks and maximiz-
ing therapy in the perioperative period.
The low incidence of bronchospasm in our review
may be the result of our institutional policies regarding
preoperative assessment and preparation of asthmatic
patients. When the otolaryngologist encounters a brittle
asthmatic patient who requires surgery, he or she usu-
ally sends that patient for pulmonary and anesthesia
TABLE I.








No. of patients 659 11 12
Sex, female, no. (%) 306 (46) 6 (55) .5927 4 (33) .4002
Age, mean (SD) 7.28 (4.04) 5.87 (4.01) .2504 5.81 (4.17) .2105
Weight, kg, mean (SD) 34.43 (25.02) 27.52 (16.89) .3618 26.09 (19.16) .2513
Length of surgery, min, mean (SD) 19.64 (11.50) 24.27 (15.89) .1891 15.17 (5.57) .0192
Preoperative oxygenation level,
oxygen saturation (SD)
98.98 (4.53) 99.0 (1.55) .9723 98.36 (3.59) .6531
Postoperative oxygenation level,
oxygen saturation (SD)
98.43 (4.15) 98.82 (1.54) .4419 98.83 (1.47) .3863
ASA status, no. 657 11 .2796 .3092
1 227 2 2
2 397 8 9
3 33 1 1
Comorbidity, no.
Asthma 177 3 .9999 10 <.0001
GERD 20 1 .2974 2 .0555
Down syndrome 12 0 .9999 1 .2108
Sickle-cell disease 6 0 .9999 0 .9999
Failure to thrive 21 0 .9999 0 .9999
Intraoperative medications, no.
Propofol 533 10 .6995 10 .9999
Dexmedetomidine 17 1 .2609 0 .9999
Sevoflurane 641 11 .9999 12 .9999
Desflurane 445 6 .3514 5 .0687
Nitrous oxide 635 11 .9999 11 .3684
Decadron 641 10 .2370 11 .2936
Antiemetic 626 10 .4386 11 .4670
Postoperative complications and management, no.
Emesis 46 1 .5541 1 .5853
Immediate bleed 3 0 .9999 0 .9999
Reintubation 3 1 .0642 0 .9999
Succinylcholine 0 3 <.0001 0 .9999
Albuterol 19 1 .2853 10 <.0001
Racemic epinephrine 5 0 .9999 1 .1031
CXR 6 0 .9999 2 .0077
Antiemetics 22 0 .9999 1 .3443
Admitted 23 0 .9999 5 <.0001
SD ¼ standard deviation; ASA ¼ American Society of Anesthesiologists; GERD ¼ gastroesophageal reflux disease; CXR ¼ chest radiograph.
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consults to alert them about the impending surgery and
the need for maximizing antiasthmatic therapy. In
addition, parents are instructed to give the patient a
nebulizer treatment on the night before surgery and the
morning of surgery as well as to be highly aware of the
need to contact the preoperative team should the patient
develop upper respiratory infection just before the
planned surgery. Furthermore, additional nebulized
albuterol is frequently given during surgery especially
just before extubation.
Our study does not resolve the controversy regard-
ing the incidence of perioperative airway complications;
however, with our large sample size and detailed review
of the anesthesia record, we believe that our conclusions
regarding the refinement in anesthesia and surgical
techniques resulting in this marked decrease in peri-
operative airway complications will be corroborated by
similar studies in the coming years.
As the rate of perioperative airway complications
has been reduced significantly, there is an onus to better
define those patients that are at risk for such. Compared
to the children without airway complications, those that
had laryngospasm showed no difference in age, weight,
ASA status, length of surgery, need for admission, and
anesthesia technique. As expected, the majority of
patients with laryngospasm (63%) were in the postopera-
tive period in the periextubation period. Interestingly,
there exists the belief and the studies to indicate that
patients with laryngospasm are younger.12 Our data
demonstrate that the patients with laryngospasm were
not very young, as their mean age was a little less than
6 years. The value of such knowledge is that the anes-
thesiologist may consider all children to be at high risk
for laryngospasm because it occurs so infrequently with
modern anesthesia techniques.
Patients with bronchospasm, compared to the
patients without complications, had faster surgeries (P
< .05), were more likely to have asthma (P < .05), and
were more likely to be admitted (P < .05). The latter two
variables are intuitive in that a reactive airway or
increased airway resistance (as noted by the underlying
asthma) certainly precludes the child to having broncho-
spasm. Furthermore, a reactive airway takes time to
stabilize and placate, and as such, these patients should
be and were admitted in our study. Knowledge of the
strong association between pediatric adenotonsillectomy,
asthma, and the resultant admission should suggest to
anesthesiologists that patients with underlying asthma
be aggressively optimized before surgery to minimize
such risk and avert a possible complication and
admission.
Despite the low prevalence and quite significant
decrease in perioperative airway complications in the
past decades, the question emerges: Who are the chil-
dren most affected and how can this risk be
appropriately mitigated? This study is an initial foray
into answering such question. In an effort to reduce
laryngospasm, attention should be focused on the intra-
operative period, particularly the periextubation period,
with the knowledge that these patients may need to be
reintubated; however, this will usually not result in an
admission. For bronchospasm, significant effort, includ-
ing perhaps formal pulmonary evaluation of severe
asthmatics before surgery, should be focused on clarify-
ing and optimizing the patient’s history of asthma as
well as including a preoperative asthma plan. One may
consider that this be done on a national level to stand-
ardize preoperative preparation of children for adenoton-
sillectomy in the setting of asthma. Not only will such
interventions be of benefit to the patient, but also
the health-care system will avoid a costly, potentially
preventable admission.
CONCLUSION
The rates of laryngospasm (1.6%) and broncho-
spasm (1.8%) reported here are lower than those
reported in the literature, reflecting modern refinements
in anesthesia and surgical technique. Knowledge of
patients vulnerable to these complications allows for
optimal anesthesia technique in high-risk patients and
may potentially further reduce the incidence of perioper-
ative airway complications during adenotonsillectomy.
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